The table below shows Cyclerion Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$2.07M
$2.00M
$0.00
$297.00K
$3.94M
$2.30M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$959.00K
$286.00K
$1.51M
$5.98M
$37.64M
$56.41M
SG&A
$6.09M
CYCN annual revenue (10-K history)
Cyclerion Therapeutics, Inc. reported annual revenue of $2.07M for fiscal year 2025. That is up 3.7% from $2.00M in fiscal 2024. Over the 7 fiscal years shown, annual revenue declined from $4.51M (FY 2019) to $2.07M. Figures come from the company's audited annual reports as filed with the SEC.